Adrian Rabin
Lawyers
Filters
Revolution Medicines $345 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Precigen $75 million follow-on offering
We advised Precigen on the SEC-registered offering
Metalmark Capital up to $50 million investment in Morgenesis
We advised Metalmark on the transaction
Medtronic Global Holdings €3.5 billion notes offering
The investment-grade notes were issued in four tranches
Novo Nordisk $1.1 billion acquisition of Forma Therapeutics
We are advising Novo Nordisk on the transaction
Legend Biotech $403 million follow-on offering
The shares are listed on the Nasdaq Global Select Market